| Cat. No. |
Name |
|
KP1102
|
LyP - 1, Peptide 2
CGNKRTRGC
|
|
KP1129
|
MAGE - 1 (161 - 169)
EADPTGHSY
|
|
KP1130
|
MAGE - 3 (271 - 279)
FLWGPRALV
|
|
KP1134
|
MARCKS Peptide (151-175)
KKKKKRFSFKKSFKLSGFSFKKNKK
|
|
KP1135
|
MARCKS Peptide (151-175), Phosphorylated
KKKKKRF-pS-FKK-pS-FKLSGF-pS-FKKNKK
|
|
KP1136
|
MARCKS Protein (154-165) [KKRFSFKKSFKL], 5-TMR labeled
5-TMR-KKRFSFKKSFKL
|
|
KP1137
|
Mastoparan
INLKALAALAKKIL-NH2
|
|
KP1139
|
Mastoparan 7
INLKALAALAKALL-NH2
|
|
KP1140
|
Mastoparan X
INWKGIAAMAKKLL-NH2
|
|
KP1156
|
MBP MAPK Substrate
APRTPGGRR
|
|
KP1158
|
MBP, MAPK Substrate, 5 - TMR labeled
5-TMR-APRTPGGRR
|
|
KP1159
|
MBP, MAPK Substrate, Biotinylated
Biotin-APRTPGGRR
|
|
KP1161
|
MBP, MAPK Substrate, Biotinylated, Phosphorylated
Biotin-APR-pT-PGGRR
|
|
KP1167
|
MCA-EDAEY(PO3)AAK(DNP)R-NH2
MCA-EDAE-pY-AAK(DNP)R-NH2
|
|
KP1171
|
MEK1 Derived Peptide Inhibitor 1
MPKKKPTPIQLNP
|
|
KP1175
|
Melanoma Antigen Family A 9B (223 - 231), MAGE - 9B (223 - 231)
ALSVMGVYV
|
|
KP1178
|
Membrane - Permeable Sequence, MPS
AAVALLPAVLLALLAK
|
|
KP1199
|
MLC-derived peptide
KKRPQRRYSNVF
|
|
KP1217
|
MPGΔNLS, HIV related;
GALFLGFLGAAGSTMGAWSQPKSKRKV
|
|
KP1218
|
MPS - Gαi3
AAVALLPAVLLALLAKNNLKECGLY
|
